feed,title,long_url,short_url
Benzinga,Orphazyme Stock Gains After FDA Update On Arimoclomol In Rare Neurodegenerative Disorder,https://benzinga.com/general/biotech/21/11/23783862/orphazyme-stock-gains-after-fda-update-on-arimoclomol-in-rare-neurodegenerative-disorder,https://j.mp/3jVi3ak
